Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis

European Journal of Immunology

Volumn 42, Issue 3, 2012, Pages 790-798

  Planas, Raquel ^a   Jelčić, Ilijas ^b   Schippling, Sven ^a,b   Martin, Roland ^a,b   Sospedra, Mireia ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

B cells; Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

NATALIZUMAB;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD COMPONENT; CELL HOMING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MALE; MARGINAL ZONE LIKE B CELL; MEMORY CELL; MULTIPLE SCLEROSIS; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; B-LYMPHOCYTES; BLOOD CELL COUNT; CELL MOVEMENT; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LONGITUDINAL STUDIES; LYMPHOID TISSUE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84859512094     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142108     Document Type: Article

References (43)

1. + T cells in cerebral perivascular spaces due to natalizumab. Arch. Neurol. 2008. 65: 1596-1603.
2. Stuve, O., Marra, C. M., Jerome, K. R., Cook, L., Cravens, P. D., Cepok, S., Frohman, E. M. et al., Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 2006. 59: 743-747.
3. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L. and Karin, N., Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992. 356: 63-66.
4. Bauer, M., Brakebusch, C., Coisne, C., Sixt, M., Wekerle, H., Engelhardt, B. and Fassler, R., Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. USA 2009. 106: 1920-1925.
5. Niino, M., Bodner, C., Simard, M. L., Alatab, S., Gano, D., Kim, H. J., Trigueiro, M. et al., Natalizumab effects on immune cell responses in multiple sclerosis. Ann. Neurol. 2006. 59: 748-754.
6. Bonig, H., Wundes, A., Chang, K. H., Lucas, S. and Papayannopoulou, T., Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood 2008. 111: 3439-3441.
7. + hematopoietic progenitor cells in humans. Blood 2008. 111: 3893-3895.
8. Jing, D., Oelschlaegel, U., Ordemann, R., Holig, K., Ehninger, G., Reichmann, H., Ziemssen, T. and Bornhauser, M., CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function. Bone Marrow Transplant. 2010. 45: 1489-1496.
9. Krumbholz, M., Meinl, I., Kumpfel, T., Hohlfeld, R. and Meinl, E., Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 2008. 71: 1350-1354.
10. Lesesve, J. F., Debouverie, M., Decarvalho Bittencourt, M. and Bene, M. C., CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes. Bone Marrow Transplant. 2011. 46: 1489-1491.
11. Skarica, M., Eckstein, C., Whartenby, K. A. and Calabresi, P. A., Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients. J. Neuroimmunol. 2011. 235: 70-76.
12. Putzki, N., Baranwal, M. K., Tettenborn, B., Limmroth, V. and Kreuzfelder, E., Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells. Eur. Neurol. 2010. 63: 311-317.
13. Kleinschmidt-DeMasters, B. K. and Tyler, K. L., Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 2005. 353: 369-374.
14. Langer-Gould, A., Atlas, S. W., Green, A. J., Bollen, A. W. and Pelletier, D., Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 2005. 353: 375-381.
15. Jilek, S., Jaquiery, E., Hirsch, H. H., Lysandropoulos, A., Canales, M., Guignard, L., Schluep, M. et al., Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Lancet Neurol. 2010. 9: 264-272.
16. Tan, C. S. and Koralnik, I. J., Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010. 9: 425-437.
17. Egli, A., Infanti, L., Dumoulin, A., Buser, A., Samaridis, J., Stebler, C., Gosert, R. and Hirsch, H. H., Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 2009. 199: 837-846.
18. Major, E. O., Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 2010. 61: 35-47.
19. Houff, S. A., Major, E. O., Katz, D. A., Kufta, C. V., Sever, J. L., Pittaluga, S., Roberts, J. R. et al., Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N. Engl. J. Med. 1988. 318: 301-305.
20. Major, E. O., Amemiya, K., Elder, G. and Houff, S. A., Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J. Neurosci. Res. 1990. 27: 461-471.
21. Monaco, M. C., Atwood, W. J., Gravell, M., Tornatore, C. S. and Major, E. O., JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J. Virol. 1996. 70: 7004-7012.
22. Atwood, W. J., Amemiya, K., Traub, R., Harms, J. and Major, E. O., Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 1992. 190: 716-723.
23. + progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Multiple Sclerosis 2011. 17: 151-156.
24. Tan, C. S., Dezube, B. J., Bhargava, P., Autissier, P., Wuthrich, C., Miller, J. and Koralnik, I. J., Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J. Infect. Dis. 2009. 199: 881-888.
25. Sabath, B. F. and Major, E. O., Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J. Infect. Dis. 2002. 186: S180-186.
26. Ransohoff, R. M., "Thinking without thinking" about natalizumab and PML. J. Neurol. Sci. 2007. 259: 50-52.
27. Jensen, P. N. and Major, E. O., Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J. Leukoc. Biol. 1999. 65: 428-438.
28. + T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch. Neurol. 2006. 63: 1383-1387.
29. Stevens, S. K., Weissman, I. L. and Butcher, E. C., Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition. J. Immunol. 1982. 128: 844-851.
30. Tang, M. L., Steeber, D. A., Zhang, X. Q. and Tedder, T. F., Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways. J. Immunol. 1998. 160: 5113-5121.
31. Kraal, G., Schornagel, K., Streeter, P. R., Holzmann, B. and Butcher, E. C., Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am. J. Pathol. 1995. 147: 763-771.
32. Lu, T. T. and Cyster, J. G., Integrin-mediated long-term B-cell retention in the splenic marginal zone. Science 2002. 297: 409-412.
33. Nakache, M., Berg, E. L., Streeter, P. R. and Butcher, E. C., The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes. Nature 1989. 337: 179-181.
34. Lo, C. G., Lu, T. T. and Cyster, J. G., Integrin-dependence of lymphocyte entry into the splenic white pulp. J. Exp. Med. 2003. 197: 353-361.
35. Dunn-Walters, D. K., Isaacson, P. G. and Spencer, J., Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 1995. 182: 559-566.
36. Wipfler, P., Oppermann, K., Pilz, G., Afazel, S., Haschke-Becher, E., Harrer, A., Huemer, M. et al., Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment. Multiple Sclerosis 2011. 17: 16-23.
37. Houff, S. A. and Berger, J. R., The bone marrow, B cells, and JC virus. J. Neurovirol. 2008. 14: 341-343.
38. DeKoter, R. P., Geadah, M., Khoosal, S., Xu, L. S., Thillainadesan, G., Torchia, J., Chin, S. S. and Garrett-Sinha, L. A., Regulation of follicular B-cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C. J. Immunol. 2011. 185: 7374-7384.
39. Kurtzke, J. F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983. 33: 1444-1452.
40. Marshall, L. J., Dunham, L. and Major, E. O., Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J. Gen. Virol. 2010. 91: 3042-3052.
41. Caldarelli-Stefano, R., Vago, L., Omodeo-Zorini, E., Mediati, M., Losciale, L., Nebuloni, M., Costanzi, G. and Ferrante, P., Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals. J. Neurovirol. 1999. 5: 125-133.
42. Tan, C. S., Ellis, L. C., Wuthrich, C., Ngo, L., Broge Jr., T. A., Saint-Aubyn, J., Miller, J. S. and Koralnik, I. J., JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J. Virol. 2010. 84: 9200-9209.
43. Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., Kappos, L., Lublin, F. D. et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005. 58: 840-846.